
Journey Medical Corp
DERMNasdaqCIK 1867066HealthcareFiscal year ends Dec 31
Reports and events: 80 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-08-0816:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-088823 |
| 2023-07-2608:30 ET | 8-K | 8.01 Other events | 0001104659-23-084082 |
| 2023-06-2316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-074239 |
| 2023-05-2216:09 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-23-063145 |
| 2023-05-2216:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001410578-23-001327 |
| 2023-04-2816:30 ET | DEF 14A | Proxy statementPeriod 2023-06-21 | 0001104659-23-053054 |
| 2023-03-3120:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001410578-23-000485 |
| 2023-03-2916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-038309 |
| 2023-01-2016:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-005408 |
| 2023-01-0317:21 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-000422 |
| 2022-11-1016:58 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001410578-22-003162 |
| 2022-11-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-117116 |
| 2022-08-0917:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001410578-22-002183 |
| 2022-08-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-087893 |
| 2022-07-2216:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-081994 |
| 2022-06-2116:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-22-072953 |
| 2022-05-1017:29 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001266 |
| 2022-05-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-058228 |
| 2022-04-2814:28 ET | DEF 14A | Proxy statementPeriod 2022-06-21 | 0001104659-22-052087 |
| 2022-03-2809:20 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001410578-22-000558 |
| 2022-03-2421:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-037193 |
| 2022-01-1307:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-003789 |
| 2021-12-1621:38 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-016853 |
| 2021-12-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-148566 |
| 2021-11-1217:29 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-21-138260 |
| 2021-11-1016:48 ET | S-1/A | Registration statement, amended | 0001104659-21-137006 |
| 2021-11-1015:03 ET | S-1/A | Registration statement, amended | 0001104659-21-136870 |
| 2021-11-1009:17 ET | S-1/A | Registration statement, amended | 0001104659-21-136695 |
| 2021-11-0809:59 ET | S-1/A | Registration statement, amended | 0001104659-21-135431 |
| 2021-10-2216:02 ET | S-1 | Registration statement | 0001104659-21-128950 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.